GLP-1 receptor agonists are transforming obesity treatment, but manufacturing challenges must be addressed to meet rising ...
In a bid to break into the CDMO business at one of its most lucrative angles, India's Granules is snapping up Swiss contract ...
Generic drugmaker Granules India is foraying into the peptide segment and contract development and manufacturing organisation ...
The Peptide-ExplorerLT ™ is designed for scientists who need to optimize and explore linear peptide synthesis. The product is a high-spec flow chemistry system that uses continuous flow. The product ...
Hyderabad: Granules India Limited has announced the signing of the acquisition agreement regarding Senn Chemicals AG, a Swiss ...
Granules India advanced 1.95% to Rs 519 after the company said that its board has approved to acquire 100% stake in Senn Chemicals AG, a Switzerland based company, for a total consideration of Rs 192.
Granules India has purchased Senn Chemicals AG, a Swiss CDMO firm specializing in peptide therapeutics, for CHF 20 million.
With this acquisition, Granules gains capabilities in high-growth peptide-based therapeutics. It also aims to enter the ...
Granules India acquires Senn Chemicals AG, expanding into peptide therapeutics and CDMO capabilities for global growth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback